Daniel Pink
- Gastroenterology top 0.2%
- Gastrointestinal Tumor Research and Treatment 52
-
- Gastric Cancer Management and Outcomes 54
- Sarcoma Diagnosis and Treatment 49
- Oncology top 5%
- Vascular Tumors and Angiosarcomas 18
- Colorectal Cancer Treatments and Studies 16
- Cancer Immunotherapy and Biomarkers 9
- Rheumatology top 5%
- Surgery top 5%
- Esophageal Cancer Research and Treatment 16
-
- Cardiac tumors and thrombi 11
- Co-authors
- Peter ReichardtPeter HohenbergerEva WardelmannPeter Thuss‐PatienceAlbrecht KretzschmarBernd DörkenDimosthenis AndreouPer‐Ulf Tunn
- Journals
- Journal of Clinical Oncology (40 papers)Annals of Oncology (18 papers)European Journal of Cancer (6 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Daniel Pink
121 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 155
- Gastroenterology 1.2k
- Pulmonary and Respiratory Medicine 1.9k
- Oncology 698
- Rheumatology 317
- Surgery 783
Countries citing papers authored by Daniel Pink
This map shows the geographic impact of Daniel Pink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Pink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Pink more than expected).
Fields of papers citing papers by Daniel Pink
This network shows the impact of papers produced by Daniel Pink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Pink. The network helps show where Daniel Pink may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Pink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 26 | |
| 10 | 2021 | 15 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 5 | |
| 13 | 2020 | 1 | |
| 14 | 2019 | 3 | |
| 15 | 2015 | 149 | |
| 16 | 2014 | 39 | |
| 17 | 2014 | 13 | |
| 18 | 2011 | 106 | |
| 19 | A Whole New Mind: Why Right Brainers will Rule the Future | 2006 | 428 |
| 20 | 2002 | 19 |
About Daniel Pink
Daniel Pink is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Oncology, having authored 130 papers that have together received 3.0k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (54 papers), Gastrointestinal Tumor Research and Treatment (52 papers), Sarcoma Diagnosis and Treatment (49 papers), Vascular Tumors and Angiosarcomas (18 papers), Esophageal Cancer Research and Treatment (16 papers), Colorectal Cancer Treatments and Studies (16 papers), Cardiac tumors and thrombi (11 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Gastroenterology (1.2k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Oncology (698 citations). Daniel Pink has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Peter Reichardt, Peter Hohenberger, Eva Wardelmann, Peter Thuss‐Patience, Albrecht Kretzschmar, Bernd Dörken, Dimosthenis Andreou, Per‐Ulf Tunn, Mathias Werner and Sebastian Bauer. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancers and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.